{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:19:31Z","timestamp":1782267571604,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,11]]},"DOI":"10.7759\/cureus.82084","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T13:04:36Z","timestamp":1744376676000},"source":"Crossref","is-referenced-by-count":1,"title":["Precision Treatment of Pulmonary Sarcoma Metastasis Using Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Anastasia","family":"Stergioula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Kormas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Kokkali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Kyriazoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaggelos","family":"Pantelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"ICRU report 91","volume":"14","author":"Menzel H-G","year":"2014","unstructured":"Menzel H-G. ICRU report 91. J Int Comm Radiat Units Meas. 2014, 14:1-160.","journal-title":"J Int Comm Radiat Units Meas"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02674-y","article-title":"UK guidelines for the management of soft tissue sarcomas","volume":"132","author":"Hayes AJ","year":"2025","unstructured":"Hayes AJ, Nixon IF, Strauss DC, et al.. UK guidelines for the management of soft tissue sarcomas. Br J Cancer. 2025, 132:11-31. 10.1038\/s41416-024-02674-y","journal-title":"Br J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5467057","article-title":"Treatment patterns and survival among adult patients with advanced soft tissue sarcoma: a retrospective medical record review in the United Kingdom, Spain, Germany, and France","volume":"2018","author":"Nagar SP","year":"2018","unstructured":"Nagar SP, Mytelka DS, Candrilli SD, et al.. Treatment patterns and survival among adult patients with advanced soft tissue sarcoma: a retrospective medical record review in the United Kingdom, Spain, Germany, and France. Sarcoma. 2018, 2018:5467057. 10.1155\/2018\/5467057","journal-title":"Sarcoma"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.100913","article-title":"Hypofractionated radiation therapy for unresectable or metastatic sarcoma lesions","volume":"7","author":"Boyce-Fappiano D","year":"2022","unstructured":"Boyce-Fappiano D, Damron EP, Farooqi A, et al.. Hypofractionated radiation therapy for unresectable or metastatic sarcoma lesions. Adv Radiat Oncol. 2022, 7:100913. 10.1016\/j.adro.2022.100913","journal-title":"Adv Radiat Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.08.028","article-title":"Stereotactic body radiation therapy for lung metastases from sarcoma in oligometastatic patients: a phase 2 study","volume":"114","author":"Navarria P","year":"2022","unstructured":"Navarria P, Baldaccini D, Clerici E, et al.. Stereotactic body radiation therapy for lung metastases from sarcoma in oligometastatic patients: a phase 2 study. Int J Radiat Oncol Biol Phys. 2022, 114:762-70. 10.1016\/j.ijrobp.2022.08.028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.05.017","article-title":"Local control outcomes using stereotactic body radiation therapy or surgical resection for metastatic sarcoma","volume":"114","author":"Gutkin PM","year":"2022","unstructured":"Gutkin PM, von Eyben R, Chin A, et al.. Local control outcomes using stereotactic body radiation therapy or surgical resection for metastatic sarcoma. Int J Radiat Oncol Biol Phys. 2022, 114:771-9. 10.1016\/j.ijrobp.2022.05.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2020.01.005","article-title":"Stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases from soft tissue sarcoma","volume":"32","author":"Tetta C","year":"2020","unstructured":"Tetta C, Londero F, Micali LR, et al.. Stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases from soft tissue sarcoma. Clin Oncol (R Coll Radiol). 2020, 32:303-15. 10.1016\/j.clon.2020.01.005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2023.06.029","article-title":"Management of oligometastatic\/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches","volume":"28","author":"Llacer-Moscardo C","year":"2024","unstructured":"Llacer-Moscardo C, Moureau-Zabotto L, Ollivier L, et al.. Management of oligometastatic\/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches. Cancer Radiother. 2024, 28:93-102. 10.1016\/j.canrad.2023.06.029","journal-title":"Cancer Radiother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.03.047","article-title":"Personalized ultrafractionated stereotactic adaptive radiotherapy (PULSAR) in preclinical models enhances single-agent immune checkpoint blockade","volume":"110","author":"Moore C","year":"2021","unstructured":"Moore C, Hsu CC, Chen WM, et al.. Personalized ultrafractionated stereotactic adaptive radiotherapy (PULSAR) in preclinical models enhances single-agent immune checkpoint blockade. Int J Radiat Oncol Biol Phys. 2021, 110:1306-16. 10.1016\/j.ijrobp.2021.03.047","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-814245-5.00002-5","article-title":"A technical overview of the CyberKnife System","author":"Kilby W","year":"2020","unstructured":"Kilby W, Naylor M, Dooley JR, Maurer CR, Sayeh S. A technical overview of the CyberKnife System. Handbook of Robotic and Image-Guided Surgery. Abedin-Nasab MH (ed): Elsevier, 2020. 15-38. 10.1016\/B978-0-12-814245-5.00002-5"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1667\/RADE-20-00226.1","article-title":"Cellular radiosensitivity of soft tissue sarcoma","volume":"196","author":"Haas RL","year":"2021","unstructured":"Haas RL, Floot BG, Scholten AN, et al.. Cellular radiosensitivity of soft tissue sarcoma. Radiat Res. 2021, 196:23-30. 10.1667\/RADE-20-00226.1","journal-title":"Radiat Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2015.11.002","article-title":"Dose and volume of the irradiated main bronchi and related side effects in the treatment of central lung tumors with stereotactic radiotherapy","volume":"26","author":"Duijm M","year":"2016","unstructured":"Duijm M, Schillemans W, Aerts JG, Heijmen B, Nuyttens JJ. Dose and volume of the irradiated main bronchi and related side effects in the treatment of central lung tumors with stereotactic radiotherapy. Semin Radiat Oncol. 2016, 26:140-8. 10.1016\/j.semradonc.2015.11.002","journal-title":"Semin Radiat Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.11.067","article-title":"Exploratory evaluation of personalized ultrafractionated stereotactic adaptive radiation therapy (PULSAR) with central nervous system-active drugs in brain metastases treatment","author":"Dohopolski M","year":"2024","unstructured":"Dohopolski M, Schmitt LG, Anand S, et al.. Exploratory evaluation of personalized ultrafractionated stereotactic adaptive radiation therapy (PULSAR) with central nervous system-active drugs in brain metastases treatment. Int J Radiat Oncol Biol Phys. 2024, 1-10. 10.1016\/j.ijrobp.2024.11.067","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13303-5","article-title":"A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol","volume":"24","author":"Courtney PT","year":"2024","unstructured":"Courtney PT, L Santoso M, Savjani RR, et al.. A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol. BMC Cancer. 2024, 24:1564. 10.1186\/s12885-024-13303-5","journal-title":"BMC Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358652-precision-treatment-of-pulmonary-sarcoma-metastasis-using-personalized-ultrafractionated-stereotactic-adaptive-radiotherapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T13:04:36Z","timestamp":1744376676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358652-precision-treatment-of-pulmonary-sarcoma-metastasis-using-personalized-ultrafractionated-stereotactic-adaptive-radiotherapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.82084","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,11]]}}}